Natac Natural Ingredients, S.A. (BME:NAT)
Spain · Delayed Price · Currency is EUR 0.6000
0.00 (0.00%)
Aug 27, 2026, 3:30 PM CET
Natac Natural Ingredients Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Rental Revenue | 47.24 | 34.72 | 22.9 | 1.08 | 1.07 |
Other Revenue | 0.59 | 0.99 | 13.21 | - | - |
| 47.83 | 35.71 | 36.11 | 1.08 | 1.07 | |
Revenue Growth (YoY | 33.94% | -1.12% | 3233.52% | 0.87% | 5.92% |
Property Expenses | 15.16 | 10.27 | 6.22 | 0.24 | 0.27 |
Selling, General & Administrative | 9.67 | 9.59 | 7.27 | - | - |
Depreciation & Amortization | 7.45 | 5.22 | 4.53 | 0.03 | 0.04 |
Other Operating Expenses | 11.55 | 9.38 | 7.02 | 1.82 | 0.86 |
Total Operating Expenses | 43.83 | 34.45 | 25.05 | 2.09 | 1.17 |
Operating Income | 3.99 | 1.26 | 11.06 | -1 | -0.09 |
Interest Expense | -4.67 | -4.31 | -4.16 | -0.56 | -0.11 |
Interest & Investment Income | 0.01 | 0 | 0.18 | 0.13 | 0 |
Currency Exchange Gain (Loss) | -0.59 | 0.25 | -0.1 | -0 | - |
Other Non-Operating Income | 3.24 | 2.99 | 1.48 | - | - |
EBT Excluding Unusual Items | 1.99 | 0.2 | 8.46 | -1.43 | -0.2 |
Gain (Loss) on Sale of Investments | - | - | - | -3.19 | 0.31 |
Asset Writedown | 0.04 | -0.13 | -0.14 | -0.02 | - |
Other Unusual Items | 0.17 | 0.18 | 0.13 | 0.15 | -0 |
Pretax Income | 2.19 | 0.25 | 8.45 | -4.49 | 0.11 |
Income Tax Expense | 1.12 | -0.15 | 2.19 | -1.39 | 0.03 |
Earnings From Continuing Operations | 1.07 | 0.4 | 6.26 | -3.1 | 0.08 |
Minority Interest in Earnings | - | - | - | 0.03 | 0 |
Net Income | 1.07 | 0.4 | 6.26 | -3.07 | 0.08 |
Net Income to Common | 1.07 | 0.4 | 6.26 | -3.07 | 0.08 |
Net Income Growth | 169.22% | -93.65% | - | - | -86.43% |
Basic Shares Outstanding | 432 | 432 | 418 | 38 | 23 |
Diluted Shares Outstanding | 432 | 432 | 418 | 38 | 23 |
Shares Change | 0.06% | 3.15% | 1008.62% | 64.11% | 4.88% |
EPS (Basic) | 0.00 | 0.00 | 0.01 | -0.08 | 0.00 |
EPS (Diluted) | 0.00 | 0.00 | 0.01 | -0.08 | 0.00 |
EPS Growth | 169.24% | -93.85% | - | - | -87.06% |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Margin | 8.35% | 3.53% | 30.64% | -92.58% | -8.52% |
Profit Margin | 2.24% | 1.11% | 17.34% | -283.72% | 7.59% |
EBITDA | 8.62 | 4.75 | 14.51 | -0.97 | -0.05 |
EBITDA Margin | 18.03% | 13.31% | 40.17% | -89.75% | -4.92% |
D&A For Ebitda | 4.63 | 3.5 | 3.44 | 0.03 | 0.04 |
EBIT | 3.99 | 1.26 | 11.06 | -1 | -0.09 |
EBIT Margin | 8.35% | 3.53% | 30.64% | -92.58% | -8.52% |
Effective Tax Rate | 51.22% | - | 25.89% | - | 29.07% |
Revenue as Reported | 47.83 | 35.85 | 26.55 | - | - |